“evercore-isi” Archives

in
Entry Author Date Location
How San Diego Biotech Leaders Are Adapting to Coronavirus Concerns 03/19/20 San Diego
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
AbbVie to Pay $63B for Allergan to Prepare for Life Without Humira 06/25/19 Detroit Ann Arbor
Second US Gene Therapy, Approved for Rare Muscle Disease, to Cost $2M 05/24/19 National
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms 05/20/19 New York
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting 05/07/19 National
Dermira Shares Soar After Eczema Drug Hits Goal of Mid-Stage Study 03/18/19 San Francisco
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Aiera Bags $3.5M for A.I. to Help Wall Street Analysts Pick Stocks 12/13/18 Boston
Report: Express Scripts Shuts Out Teva Migraine Drug, Prefers Rivals 10/17/18 National
Bristol Stumbles in Lung Cancer Again as Rivals Play Catch-Up 10/12/18 New York
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines 09/28/18 Indiana
Teva Wins FDA Nod for Migraine Drug, Sets Price in Line with Amgen’s 09/14/18 National
Pain Drug Race Continues as Regeneron Posts Early Phase 3 Results 08/16/18 New York
Eisai & Biogen Reveal Promising Alzheimer’s Data, But Questions Linger 07/26/18 Boston
Acceleron’s Blood Drug Hits Phase 3 Goals, Paves Way for FDA Filing 06/28/18 Boston
Allergan’s Migraine-Reducing Pill Hits Study Goals, Heads to Phase 3 06/11/18 New York
Drug Price Watchdog ICER Deems Amgen Migraine Drug “Cost-Effective” 06/01/18 National
Teva Migraine Drug Likely Delayed by Manufacturing Trouble 02/08/18 National
Bristol-Myers Immune Drug Combo Hits Early Mark in Lung Cancer Study 02/05/18 New York
Biogen, Eisai Alzheimer’s Drug Fails First Test But Study Continues 12/21/17 Boston
Chemo Tops Pfizer, Merck KGaA Drug in Big Stomach Cancer Test 11/28/17 New York
Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer 08/16/17 New York
Teva Seeks to Keep Pace in Migraine Drug Race With Trial Results 05/31/17 New York
Celgene’s Data Could Lead To New Option For Multiple Sclerosis Patients 05/22/17 New York
Merck Immunotherapy Drug Notches Another FDA Win in Lung Cancer 05/11/17 New York
Insurer UHC Will Cover Biogen Spine Drug, But With Limits And Proof 02/02/17 Boston
New Data Show Biogen, Ionis Drug Might Help More With Rare Spine Disease 11/07/16 Boston
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
Amgen Bests Sanofi-Regeneron In PCSK9 Patent Case, Losers Vow Appeal 03/16/16 New York
Page 1 of 1